Xiu et al., have reported that malignant B-cells produced IL-10 in NHL patients thus promoted the decrease in MHCII expression on monocytes and the increase in the percentage of CD14+HLA-DRlow/− cells [13]. The gene discussed is IL10; the disease is non-Hodgkin lymphoma.